- Home
- FORTY vs IMCR Comparison
FORTY vs IMCR Comparison
Compare FORTY & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORTY
- IMCR
- Stock Information
- Founded
- FORTY 1985
- IMCR 2008
- Country
- FORTY Israel
- IMCR United Kingdom
- Employees
- FORTY N/A
- IMCR N/A
- Industry
- FORTY EDP Services
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FORTY Technology
- IMCR Health Care
- Exchange
- FORTY Nasdaq
- IMCR Nasdaq
- Market Cap
- FORTY 1.3B
- IMCR 1.5B
- IPO Year
- FORTY 1997
- IMCR 2021
- Fundamental
- Price
- FORTY $97.11
- IMCR $28.40
- Analyst Decision
- FORTY
- IMCR Buy
- Analyst Count
- FORTY 0
- IMCR 11
- Target Price
- FORTY N/A
- IMCR $59.11
- AVG Volume (30 Days)
- FORTY 603.0
- IMCR 265.8K
- Earning Date
- FORTY 05-21-2025
- IMCR 05-07-2025
- Dividend Yield
- FORTY 1.56%
- IMCR N/A
- EPS Growth
- FORTY 23.49
- IMCR N/A
- EPS
- FORTY 5.09
- IMCR N/A
- Revenue
- FORTY $2,757,511,000.00
- IMCR $333,581,000.00
- Revenue This Year
- FORTY N/A
- IMCR $20.26
- Revenue Next Year
- FORTY N/A
- IMCR $8.49
- P/E Ratio
- FORTY $18.23
- IMCR N/A
- Revenue Growth
- FORTY 5.21
- IMCR 25.75
- 52 Week Low
- FORTY $69.07
- IMCR $23.15
- 52 Week High
- FORTY $100.00
- IMCR $62.22
- Technical
- Relative Strength Index (RSI)
- FORTY 72.48
- IMCR 45.68
- Support Level
- FORTY $85.30
- IMCR $27.88
- Resistance Level
- FORTY $87.57
- IMCR $31.38
- Average True Range (ATR)
- FORTY 1.50
- IMCR 1.60
- MACD
- FORTY 0.79
- IMCR -0.08
- Stochastic Oscillator
- FORTY 55.49
- IMCR 22.19
About FORTY Formula Systems (1985) Ltd.
Formula Systems (1985) Ltd is a holding company that, through its subsidiaries, provides information technology services. The company organizes itself into operating segments: The Matrix segment, which generates the majority of revenue, provides software development and existing software expansion services. The Sapiens segment provides software development services for the insurance industry. The Magic Software segment provides vendor management systems and workforce management services, which include accounting and finance, human resources; Michpal; ZAP Group and Others. The majority of the company's revenue comes from Israel.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.